PLI boost: Cancer patients can hope for affordable drugs in India
New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...
Medscape10d
Short-Term Safety and Tolerability of Double-Dose Salmeterol/Fluticasone Propionate in Adult Asthmatic Patients
Other salmeterol-related adverse events (palpitations ... doubling the dose of Seretide™ administered via a Diskus™ inhaler in subjects with varying degrees of asthma is safe and well ...
Verywell Health on MSN12d
9 Key Signs You May Be Having an Asthma Attack
An asthma attack can come on suddenly or as a gradual worsening of symptoms. Here are the key signs you may be experiencing ...
pharmaphorum8d
Teva launches digital asthma and COPD rescue inhaler in US
Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).
pharmaphorum5d
Mylan launches Advair generic at 70% discount in US
The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired in 2016. But Mylan became the first of a group of potential ...
thorax.bmj13d
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy
In 63 studies in which patients were randomised to receive the combination salmeterol/fluticasone propionate inhaler or ICS, there were no asthma deaths among 22 600 patients. Conclusions: Salmeterol ...